Markets

Tuesday 8/26 Insider Buying Report: BIOA, CACB

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned dollars to make a purchase, is that they expect to make money. Today we look at two noteworthy recent insider buys.

On Monday, BioAmber ( BIOA )'s Director, Kurt W. Briner, made a $163,875 purchase of BIOA, buying 14,250 shares at a cost of $11.50 each. So far Briner is in the green, up about 5.7% on their purchase based on today's trading high of $12.15. BioAmber is trading trading flat on the day Tuesday. Before this latest buy, Briner purchased BIOA on 2 other occasions during the past year, for a total investment of $36,418 at an average of $11.45 per share.

And at Cascade Bancorp ( CACB ), there was insider buying on Thursday, by EVP-Chief Credit Officer Daniel J. Lee who bought 25,000 shares for a cost of $5.34 each, for a total investment of $133,448. Before this latest buy, Lee bought CACB on 2 other occasions during the past twelve months, for a total investment of $177,387 at an average of $4.34 per share. Cascade Bancorp is trading off about 0.4% on the day Tuesday.

VIDEO: Tuesday 8/26 Insider Buying Report: BIOA, CACB

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Other Topics

Investing

Latest Markets Videos